Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

収録刊行物

被引用文献 (3)*注記

もっと見る

問題の指摘

ページトップへ